Ashiq Mubarack

Item: Ashiq Mubarack
Rating: 0.78
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.78)

# 4,027

Out of 5,113 analysts

Total ratings

66.67%

Success rate

-18.49%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$150 → $125	$29.03	+330.59%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$5.07	+57.79%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $150 → $125

Current: $29.03

Upside: +330.59%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $5.07

Upside: +57.79%